TR201902205T4 - Glisiretinik asit türevi ve kullanımı. - Google Patents

Glisiretinik asit türevi ve kullanımı. Download PDF

Info

Publication number
TR201902205T4
TR201902205T4 TR2019/02205T TR201902205T TR201902205T4 TR 201902205 T4 TR201902205 T4 TR 201902205T4 TR 2019/02205 T TR2019/02205 T TR 2019/02205T TR 201902205 T TR201902205 T TR 201902205T TR 201902205 T4 TR201902205 T4 TR 201902205T4
Authority
TR
Turkey
Prior art keywords
acid derivative
glycyrretinic acid
glycyrretinic
glycyrrhetinic acid
represented
Prior art date
Application number
TR2019/02205T
Other languages
English (en)
Inventor
Takeuchi Hideyuki
Suzumura Akio
Original Assignee
Suzumura Akio
Takeuchi Hideyuki
Ini Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suzumura Akio, Takeuchi Hideyuki, Ini Corp filed Critical Suzumura Akio
Publication of TR201902205T4 publication Critical patent/TR201902205T4/tr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Bir yeni glisiretinik asit türevi açıklanmaktadır. Glisiretinik asit türevi aşağıdaki genel formül (1) ile temsil edilmektedir.
TR2019/02205T 2013-11-25 2014-11-20 Glisiretinik asit türevi ve kullanımı. TR201902205T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013243130 2013-11-25

Publications (1)

Publication Number Publication Date
TR201902205T4 true TR201902205T4 (tr) 2019-03-21

Family

ID=53179585

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/02205T TR201902205T4 (tr) 2013-11-25 2014-11-20 Glisiretinik asit türevi ve kullanımı.

Country Status (11)

Country Link
US (1) US9796751B2 (tr)
EP (1) EP3075738B1 (tr)
JP (1) JP6227665B2 (tr)
CA (1) CA2931492C (tr)
DK (1) DK3075738T3 (tr)
ES (1) ES2719330T3 (tr)
HU (1) HUE042429T2 (tr)
PL (1) PL3075738T3 (tr)
PT (1) PT3075738T (tr)
TR (1) TR201902205T4 (tr)
WO (1) WO2015076325A1 (tr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3539974T5 (en) 2016-11-09 2024-05-27 Univ Osaka Method for modifying t cell population

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100488979C (zh) 2005-10-14 2009-05-20 天津药物研究院 甘草次酸-30-酰胺类衍生物及其用途
WO2007088712A1 (ja) 2006-02-02 2007-08-09 National University Corporation Nagoya University 神経細胞の細胞死阻害剤及びスクリーニング方法
WO2010007788A1 (ja) * 2008-07-16 2010-01-21 株式会社アイ・エヌ・アイ グリチルレチン酸誘導体及びその利用
EP2228380A1 (en) 2009-03-13 2010-09-15 onepharm Research & Development GmbH Novel triterpene derivatives
US9457030B2 (en) * 2012-10-29 2016-10-04 Board Of Regents Of The University Of Nebraska Compositions and methods for the treatment of juvenile neuronal ceroid lipofuscinosis and related disorders

Also Published As

Publication number Publication date
US9796751B2 (en) 2017-10-24
EP3075738A1 (en) 2016-10-05
PT3075738T (pt) 2019-04-30
CA2931492A1 (en) 2015-05-28
ES2719330T3 (es) 2019-07-09
US20160376303A1 (en) 2016-12-29
HUE042429T2 (hu) 2019-06-28
EP3075738B1 (en) 2019-02-13
DK3075738T3 (en) 2019-04-23
JPWO2015076325A1 (ja) 2017-03-16
EP3075738A4 (en) 2017-10-11
WO2015076325A1 (ja) 2015-05-28
PL3075738T3 (pl) 2019-09-30
JP6227665B2 (ja) 2017-11-08
CA2931492C (en) 2020-03-24

Similar Documents

Publication Publication Date Title
AR117799A2 (es) Sal(es) de dimetil-amida del ácido 7-ciclopentil-2-(5-piperazin-1-il-piridin-2-il-amino)-7h-pirrolo-[2,3-d]-pirimidin-6-carboxílico y procesos para su elaboración
CR20150509A (es) Derivados de naftiridina utiles como antagonistas de la alfa-v-beta-6 integrina
UY34585A (es) Compuestos b-lactámicos sustituidos con amidina, su preparación y uso
UY34797A (es) Uracilos sustituidos bicíclicamente y uso de los mismos
EA201591349A1 (ru) Способ получения вортиоксетина
EA201690894A1 (ru) Феноксиэтилы
TWD191348S (zh) 盲鉚釘緊固裝置
TR201819419T4 (tr) Yeni tetrahidropiridopirimidin bileşiği veya tuzu.
BR112015028876A2 (pt) derivados de perhidroquinoxalina
TR201901516T4 (tr) Nöroprotektif ajanlar ve bunların kullanımları.
UY37384A (es) Picolinamidas como fungicidas
RU2012113763A (ru) Ненасыщенные блок-сополиэфирсульфоны
TR201902205T4 (tr) Glisiretinik asit türevi ve kullanımı.
RU2013130187A (ru) Ароматические блок-сополиэфиры
DOP2017000016A (es) Nueva sal de disoproxilo de tenofovir
TR201819166T4 (tr) Anti̇kanser akti̇vi̇teye sahi̇p yeni̇ ti̇yosemi̇karbazon şelatlari
RU2013142538A (ru) Ароматические полиэфирсульфонкетоны
RU2013142570A (ru) Ароматические полиэфирсульфонкетоны
RU2013142536A (ru) Ароматические полиэфирсульфонкетоны
RU2013140602A (ru) Ароматические полиэфирсульфонкетоны
RU2013134779A (ru) 2-(5-этил-1,3,4-тиадиазолил)амид 2-(4-бромфенил)-4-оксо-4-фенил-2-бутеновой кислоты, обладающий анальгетической активностью
RU2013139822A (ru) Ароматические полиэфирсульфонкетоны
RU2011116802A (ru) 1-(1-адамантил)-4-нитрозопиразолы
PL405775A1 (pl) Nowy związek, zwłaszcza do stosowania jako pigment
RU2012118848A (ru) Средство для стимуляции роста волос